Japan tobacco and d-wave announce quantum proof-of-concept outperforms classical results for llm training in drug discovery

Palo alto, calif.--(business wire)--d-wave quantum inc. (nyse: qbts) (“d-wave” or the “company”), a leader in quantum computing systems, software, and services, and the pharmaceutical division of japan tobacco inc. (“jt”) today announced the completion of a joint proof-of-concept project that used quantum computing technology and artificial intelligence (ai) in the drug discovery process. jt and d-wave enhanced large language models (llms) with a quantum-hybrid workflow to increase their genera.
QMCO Ratings Summary
QMCO Quant Ranking